A
AN2 Therapeutics, Inc.
ANTX · NASDAQ · Healthcare · 216M
Closing price
$4.40
-5.98% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.5×
Enterprise value / EBITDAEV/EBITDA
-3.2×
Free cash flow yieldFCF yield
-22.4%
Return on equityROE
-66.3%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.